Rockwell Medical (RMTI) stock could double by 2027 despite recent selloff, says Seeking Alpha analyst. Read more here.
Piper Jaffray has recently initiated Rockwell Medical Inc (RMTI) stock to Overweight rating, as announced on June 24, 2019, according to Finviz. Earlier, on May 13, 2019, H.C. Wainwright had ...
Anthony Vendetti, an analyst from Maxim Group, maintained the Buy rating on Rockwell Med (RMTI – Research Report). The associated price ...
However, my previous bullish call almost broke even last week - this was thwarted by the price action following the Q3 FY2024 ...
On Wednesday, Rockwell Medical Inc (RMTI) stock saw a decline, ending the day at $2.63 which represents a decrease of $-0.20 or -7.07% from the prior close of $2.83. The stock opened at $3 and touched ...
Rockwell Medical (NASDAQ:RMTI – Get Free Report) is scheduled to announce its earnings results before the market opens on ...
Rockwell Medical ( (RMTI) ) has released its Q3 earnings. Here is a breakdown of the information Rockwell Medical presented to its investors.
Rockwell Medical (RMTI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.07 per share a year ago.